These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Itamycin, a new antibiotic. I. Isolation, biological and physicochemical properties]. Lyra FD, de Lima OG, de Méllo JF, Coêlho JS, de Albuquerque MM, Cavalcanti Mda S, de Oliveira LL. Rev Inst Antibiot (Recife); 1968 Dec; 8(1):49-60. PubMed ID: 5761011 [No Abstract] [Full Text] [Related]
23. [Metabolic products of microorganisms. 87. L-2,5-Dihydrophenylalanine]. Fickenscher U, Keller-Schierlein W, Zähner H. Arch Mikrobiol; 1971 Dec; 75(4):346-52. PubMed ID: 4323576 [No Abstract] [Full Text] [Related]
24. [The antiviral effect of the Streptomyces antibiotic IMET A 8136-A (borrelidin) on the classical fowl plague virus in vitro]. Tonew E, Eckardt K, Fleck W, Zöpel P. Z Allg Mikrobiol; 1970 Dec; 10(5):353-61. PubMed ID: 5529669 [No Abstract] [Full Text] [Related]
27. [Development of new technology for isolation of nebramycin complex antibiotics from the cultural fluid]. Nogovitsyna LV, Mikhaĭlov VA, Kharechko AT, Sadovoĭ NV. Antibiot Khimioter; 2004 Dec; 49(1):4-7. PubMed ID: 15164516 [Abstract] [Full Text] [Related]
29. Actinomycetes studies. 1. Microbiological synthesis of quinazomycin, an echinomycin analogue containing one quinazol-4-one-3-acetyl residue. Khan AW, Bhaduri AP, Gupta CM, Dhar MM. Indian J Biochem; 1969 Dec; 6(4):220-1. PubMed ID: 4245426 [No Abstract] [Full Text] [Related]
30. Aspiculamycin, a new cytosine nucleoside antibiotic. I. Producing organism, fermentation and isolation. Arai M, Haneishi T, Enokita R, Kayamori H. J Antibiot (Tokyo); 1974 May; 27(5):329-33. PubMed ID: 4850654 [No Abstract] [Full Text] [Related]
31. Siamycins I and II, new anti-HIV peptides: I. Fermentation, isolation, biological activity and initial characterization. Tsunakawa M, Hu SL, Hoshino Y, Detlefson DJ, Hill SE, Furumai T, White RJ, Nishio M, Kawano K, Yamamoto S. J Antibiot (Tokyo); 1995 May; 48(5):433-4. PubMed ID: 7797448 [No Abstract] [Full Text] [Related]
33. Purification and partial characterization of an antibiotic produced by Myxococcus xanthus. Vaks B, Zuckerberg A, Rosenberg E. Can J Microbiol; 1974 Feb; 20(2):155-61. PubMed ID: 4362757 [No Abstract] [Full Text] [Related]
34. Utilization of a lipid substrate for submerged fermentation of Streptomyces albus. Procházka P, Nohýnek M, Vanĕk Z, Rokos J. Folia Microbiol (Praha); 1983 Feb; 28(5):406-8. PubMed ID: 6642320 [Abstract] [Full Text] [Related]
35. Staphylococcal micrococcins. II. Isolation, purification and identification. Breiter J, Metz H, Grigo J. Arzneimittelforschung; 1975 Aug; 25(8):1244-8. PubMed ID: 241360 [Abstract] [Full Text] [Related]
40. A new antiherpetic agent, AH-135Y, produced by Streptomyces albovinaceus strain No. AH-135. Uyeda M, Aoki M, Nakajima K, Shiromoto C, Tatsuguchi N, Yokomizo K, Kido Y, Kino Y. J Antibiot (Tokyo); 1992 Aug; 45(8):1370-2. PubMed ID: 1328125 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]